News
News and presentations
Press releases, conference data and company news since our founding in 2019.
Press releases
-
Press releases
Tacalyx secures €11 million to advance lead TACA-targeting ADC programme toward the clinic
€11 million from the existing syndicate in a first closing of the seed extension. TCX-201 is selected as first clinical candidate, with a CTA filing planned for 2027.
-
Press releases
Tacalyx appoints Jean Engela as Chief Executive Officer to spearhead next phase of growth
The former CEO of ADC company NBE Therapeutics takes over from co-founder Dr. Peter Sondermann, who continues as Chief Scientific Officer.
-
Press releases
Tacalyx extends seed round to over €14 million
New investor Thuja Capital leads the extension; Evan Castiglia joins the Board of Directors.
-
Press releases
Tacalyx and Leiden University Medical Center join forces to target tumor-specific glycans in colorectal cancer
A €500k Health~Holland grant funds a collaboration with Prof. Manfred Wuhrer's team on the O-glycome of colorectal cancer.
-
Press releases
Tacalyx raises €7 million in seed funding to generate first-in-class anti-TACA antibodies for cancer treatment
The Max Planck spin-out launches with a syndicate co-led by Boehringer Ingelheim Venture Fund and Kurma Partners.
Media inquiries: contact